Dr. Reddy’s Laboratories launches Sodium Nitroprusside Injection

30 Dec 2019 Evaluate

Dr. Reddy's Laboratories has launched Sodium Nitroprusside Injection, 50 mg/2 ml (25 mg/ml) Single-dose Vial, the therapeutic generic equivalent of Nitropress (sodium nitroprusside) Injection, 50 mg/2ml vial, approved by the U.S. Food and Drug Administration (USFDA).

The Nitropress brand and generics had U.S. sales of approximately $8 million MAT for the most recent twelve months ending in October 2019 according to IQVIA Health. The company’s Sodium Nitroprusside Injection is available in single-dose 50 mg/2 ml (25 mg/ml) vials.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharm aceuticals in India and overseas.

Dr. Reddys Lab Share Price

1254.65 -27.30 (-2.13%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×